8-K
filed February 28, 2023, 6:59 PM ET
ticker SKIN
CIK 0001818093
earnings
confidence high
sentiment positive
materiality 0.75
BeautyHealth reports FY2022 net sales $365.9M (+41% YoY); guides FY2023 $450-470M
SkinHealth Systems Inc.
2022-FY EPS reported
-$0.23
revenue$365,876,000
- Full year net sales $365.9M (+41% YoY); Q4 net sales $98.1M (+26% YoY).
- Full year net income $44.4M vs net loss $375.1M in 2021; adjusted EBITDA $47.7M (+46% YoY).
- Guides FY2023 net sales $450-470M; affirms 18-20% adjusted EBITDA margin target.
- Confirms long-range 2025 guidance: net sales $600-700M, 25-30% adjusted EBITDA margin.
- Syndeo launch and China expansion key drivers; 8,492 delivery systems sold in 2022.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
SkinHealth Systems Inc. reported the full year ended December 31, 2022 results: revenue $365.9 million, net income $44.4 million. Guidance reaffirmed.
- Period
- the full year ended December 31, 2022
- Revenue
- $365.9 million
- Net income
- $44.4 million
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
Full year 2022 net sales of $365.9 million increased +41% relative to 2021, and fourth quarter net sales of $98.1 million increased +26%, revealing consistent mid-to-high double-digit quarterly growth year-over-year. The Company delivered net income of $44.4 million and adjusted EBITDA of $47.7 million for the full year, up +46% relative to 2021, and net income of $3.8 million and adjusted EBITDA of $16.3 million for the fourth quarter, up +92% relative to the fourth quarter of 2021.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
SkinHealth Systems Inc. reported the fourth quarter ended December 31, 2022 results: revenue $98.1 million, net income $3.8 million. Guidance reaffirmed.
- Period
- the fourth quarter ended December 31, 2022
- Revenue
- $98.1 million
- Net income
- $3.8 million
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
Full year 2022 net sales of $365.9 million increased +41% relative to 2021, and fourth quarter net sales of $98.1 million increased +26%, revealing consistent mid-to-high double-digit quarterly growth year-over-year. The Company delivered net income of $44.4 million and adjusted EBITDA of $47.7 million for the full year, up +46% relative to 2021, and net income of $3.8 million and adjusted EBITDA of $16.3 million for the fourth quarter, up +92% relative to the fourth quarter of 2021.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.